Federal regulators’ inaction on the 340B program’s interactions with Medicare drug price negotiations will likely lead drugmakers to pursue “manufacturer-friendly” [...] …
Year: 2024
Federally qualified health centers (FQHCs) appear to use their 340B program savings to enhance safety-net care, according to a new [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The leader of a right-leaning think tank that’s received funding from the drug industry criticized pushback that led Johnson & [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
340B PROVIDER LEADER SPOTLIGHT
Edline Victor, Director of Pharmacy, Whole Family Health Center and 2024 Scholarship Recipient for the Apexus Advanced 340B Operations Certificate Program
Q: Where did you go to college/graduate school?
I completed a bachelor’s in biomedical sciences with a minor in public health from the University of South Florida
…
SPONSORED CONTENT
TIP: Covered entities must protect their 340B programs from manufacturers attempting to reduce savings and eligibility.
A new federal regulation updating the definition of a covered outpatient drug could change the number of drugs covered under [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Specialty pharmacy Senderra Rx will no longer dispense GlaxoSmithKline’s (GSK’s) asthma treatment Nucala, the drug manufacturer announced on industry vendor [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Amgen announced a change to the national drug code (NDC) for its osteoporosis drug, Prolia. The California-based drug giant [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Arkansas Begins Enforcement Against AstraZeneca for Allegedly Violating Contract Pharmacy Access Law
Arkansas officials initiated enforcement proceedings earlier this week against AstraZeneca for allegedly violating a state law that prohibits drugmaker 340B [...] …
